

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.77507753 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.65746289 |
| 3 | vocalization behavior (GO:0071625) | 5.41662918 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.39814516 |
| 5 | glutamate secretion (GO:0014047) | 5.06394049 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.01313444 |
| 7 | sodium ion export (GO:0071436) | 4.96811798 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.89376515 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.86314332 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.77792060 |
| 11 | protein localization to synapse (GO:0035418) | 4.74218776 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.69967963 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.66645020 |
| 14 | cerebellar granule cell differentiation (GO:0021707) | 4.61093042 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.54872431 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.47752492 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.36583597 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.33415832 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.27423467 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.21468754 |
| 21 | neuronal ion channel clustering (GO:0045161) | 4.18775002 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.17565543 |
| 23 | potassium ion homeostasis (GO:0055075) | 4.08228072 |
| 24 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.03454827 |
| 25 | proline transport (GO:0015824) | 4.01997690 |
| 26 | exploration behavior (GO:0035640) | 4.00112459 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 3.99210208 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.91205952 |
| 29 | positive regulation of dendritic spine development (GO:0060999) | 3.89649910 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.85964708 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.83650434 |
| 32 | L-amino acid import (GO:0043092) | 3.81500063 |
| 33 | neurotransmitter transport (GO:0006836) | 3.81489133 |
| 34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.80652579 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.74387866 |
| 36 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.72512446 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.72471470 |
| 38 | neuron recognition (GO:0008038) | 3.72144143 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71135514 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.66061301 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.65684218 |
| 42 | establishment of mitochondrion localization (GO:0051654) | 3.63690432 |
| 43 | presynaptic membrane assembly (GO:0097105) | 3.61865599 |
| 44 | regulation of neurotransmitter levels (GO:0001505) | 3.60521623 |
| 45 | postsynaptic membrane organization (GO:0001941) | 3.59064492 |
| 46 | regulation of synapse maturation (GO:0090128) | 3.58912335 |
| 47 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.57781914 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57498060 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 3.57140121 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57109066 |
| 51 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.55651215 |
| 52 | neuromuscular process controlling balance (GO:0050885) | 3.54761837 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.50906590 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.50200221 |
| 55 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.48876725 |
| 56 | amino acid import (GO:0043090) | 3.48406549 |
| 57 | auditory behavior (GO:0031223) | 3.48050907 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.46989773 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.46777317 |
| 60 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.46492051 |
| 61 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.46492051 |
| 62 | potassium ion import (GO:0010107) | 3.45805307 |
| 63 | positive regulation of synapse maturation (GO:0090129) | 3.45002991 |
| 64 | axon ensheathment in central nervous system (GO:0032291) | 3.42286603 |
| 65 | central nervous system myelination (GO:0022010) | 3.42286603 |
| 66 | cell communication by electrical coupling (GO:0010644) | 3.41624731 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.40231983 |
| 68 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.39949811 |
| 69 | neuromuscular synaptic transmission (GO:0007274) | 3.39048467 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.38646265 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36792255 |
| 72 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.36380577 |
| 73 | response to histamine (GO:0034776) | 3.36307832 |
| 74 | regulation of neurotransmitter secretion (GO:0046928) | 3.36039175 |
| 75 | presynaptic membrane organization (GO:0097090) | 3.35934819 |
| 76 | synaptic vesicle endocytosis (GO:0048488) | 3.35904440 |
| 77 | regulation of ARF protein signal transduction (GO:0032012) | 3.33745518 |
| 78 | cell differentiation in hindbrain (GO:0021533) | 3.32500585 |
| 79 | regulation of vesicle fusion (GO:0031338) | 3.31638418 |
| 80 | mating behavior (GO:0007617) | 3.29713053 |
| 81 | cerebellar Purkinje cell layer development (GO:0021680) | 3.28383702 |
| 82 | activation of protein kinase A activity (GO:0034199) | 3.28074216 |
| 83 | transferrin transport (GO:0033572) | 3.27574979 |
| 84 | positive regulation of membrane potential (GO:0045838) | 3.27566975 |
| 85 | long-term memory (GO:0007616) | 3.27343127 |
| 86 | dendritic spine organization (GO:0097061) | 3.26857322 |
| 87 | synapse assembly (GO:0007416) | 3.26700638 |
| 88 | cellular sodium ion homeostasis (GO:0006883) | 3.26601405 |
| 89 | long-term synaptic potentiation (GO:0060291) | 3.25491359 |
| 90 | transmission of nerve impulse (GO:0019226) | 3.24400386 |
| 91 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.23526347 |
| 92 | mitochondrion transport along microtubule (GO:0047497) | 3.23526347 |
| 93 | regulation of glutamate secretion (GO:0014048) | 3.23480127 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 3.22719962 |
| 95 | positive regulation of neurotransmitter transport (GO:0051590) | 3.22172781 |
| 96 | neuromuscular process controlling posture (GO:0050884) | 3.21425215 |
| 97 | regulation of synaptic transmission (GO:0050804) | 3.20333315 |
| 98 | cell migration in hindbrain (GO:0021535) | 3.18062809 |
| 99 | positive regulation of synapse assembly (GO:0051965) | 3.16800986 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.15876563 |
| 101 | axonal fasciculation (GO:0007413) | 3.15568515 |
| 102 | regulation of synaptic plasticity (GO:0048167) | 3.13216878 |
| 103 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.12256304 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.12126892 |
| 105 | behavioral response to cocaine (GO:0048148) | 3.12085385 |
| 106 | membrane depolarization (GO:0051899) | 3.11365752 |
| 107 | negative regulation of microtubule polymerization (GO:0031115) | 3.10689731 |
| 108 | establishment of synaptic vesicle localization (GO:0097480) | 3.09970755 |
| 109 | synaptic vesicle transport (GO:0048489) | 3.09970755 |
| 110 | synaptic transmission (GO:0007268) | 3.08637083 |
| 111 | adult walking behavior (GO:0007628) | 3.08395886 |
| 112 | neurofilament cytoskeleton organization (GO:0060052) | 3.07260687 |
| 113 | synaptic transmission, dopaminergic (GO:0001963) | 3.06125867 |
| 114 | ferric iron transport (GO:0015682) | 3.02905557 |
| 115 | trivalent inorganic cation transport (GO:0072512) | 3.02905557 |
| 116 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02396640 |
| 117 | membrane hyperpolarization (GO:0060081) | 3.02354497 |
| 118 | prepulse inhibition (GO:0060134) | 3.02053033 |
| 119 | dendritic spine morphogenesis (GO:0060997) | 3.00968006 |
| 120 | behavioral defense response (GO:0002209) | 2.99469223 |
| 121 | behavioral fear response (GO:0001662) | 2.99469223 |
| 122 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.99456576 |
| 123 | striatum development (GO:0021756) | 2.97332964 |
| 124 | negative regulation of dendrite development (GO:2000171) | 2.96612972 |
| 125 | innervation (GO:0060384) | 2.95556818 |
| 126 | social behavior (GO:0035176) | 2.94919641 |
| 127 | intraspecies interaction between organisms (GO:0051703) | 2.94919641 |
| 128 | fear response (GO:0042596) | 2.94732147 |
| 129 | cellular potassium ion homeostasis (GO:0030007) | 2.94563643 |
| 130 | regulation of protein kinase A signaling (GO:0010738) | 2.93614270 |
| 131 | behavioral response to ethanol (GO:0048149) | 2.93459348 |
| 132 | positive regulation of synaptic transmission (GO:0050806) | 2.93039984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.97183464 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.15281048 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23413477 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04478127 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00653710 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.86451111 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.70440215 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64998848 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63262029 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.62086850 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59111160 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59111160 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55584391 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54141395 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50445184 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44586062 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42460538 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.38203443 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31037088 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.28832230 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.22700854 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.22573370 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.20535507 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15403010 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10474751 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09174575 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.06704517 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06437381 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02079268 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01675832 |
| 31 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.00740443 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92997763 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.86702583 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83270928 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.80134574 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78664674 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.75255592 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69518004 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69425451 |
| 40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64184905 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62326630 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60125571 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60015573 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.58533535 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56665972 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55168411 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.51268336 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.50147912 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49748392 |
| 50 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.47955363 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45264030 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45111184 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42790955 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42406766 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42195848 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39996303 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38933998 |
| 58 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38795663 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38784321 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38071346 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37544349 |
| 62 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.36109164 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35583648 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35410516 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34104664 |
| 66 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.33580490 |
| 67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31951343 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30959904 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30724596 |
| 70 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.30334872 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29489208 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27823382 |
| 73 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.27792476 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26114624 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24208479 |
| 76 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23845697 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22355135 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22303869 |
| 79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21065792 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20869017 |
| 81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19161447 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18333474 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 1.15350003 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14562136 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13317810 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11633439 |
| 87 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10796427 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10536927 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10521500 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09960434 |
| 91 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09505552 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08041422 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07571797 |
| 94 | AR_19668381_ChIP-Seq_PC3_Human | 1.06651115 |
| 95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05228032 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02390486 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02297916 |
| 98 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00353616 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99038020 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97621916 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97028912 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96777264 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95628348 |
| 104 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95550267 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95023170 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94654850 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94053931 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93137541 |
| 109 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.91961368 |
| 110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90658369 |
| 111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90600971 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90572588 |
| 113 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90376132 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90189359 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89600187 |
| 116 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.89482914 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88712314 |
| 118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88712314 |
| 119 | * P68_20966046_ChIP-Seq_HELA_Human | 0.88171046 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87929600 |
| 121 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87409367 |
| 122 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86852022 |
| 123 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85823696 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85212504 |
| 125 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84088716 |
| 126 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84032283 |
| 127 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84032283 |
| 128 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83086136 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82491735 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82058977 |
| 131 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.81397121 |
| 132 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.79983291 |
| 133 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.77157738 |
| 134 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.76088161 |
| 135 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.75526743 |
| 136 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.75214288 |
| 137 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73956716 |
| 138 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.72764036 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.69900373 |
| 140 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.69149599 |
| 141 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.68405152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.19292567 |
| 2 | MP0003880_abnormal_central_pattern | 5.06324374 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.84320335 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.57928728 |
| 5 | MP0004270_analgesia | 3.42594795 |
| 6 | MP0009745_abnormal_behavioral_response | 3.34162397 |
| 7 | MP0002064_seizures | 3.13174577 |
| 8 | MP0002736_abnormal_nociception_after | 3.11051204 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.09086301 |
| 10 | MP0009046_muscle_twitch | 3.07840913 |
| 11 | MP0002822_catalepsy | 3.05767919 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.99223811 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.98066576 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.84021123 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.78971972 |
| 16 | MP0002272_abnormal_nervous_system | 2.58502901 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.57506993 |
| 18 | MP0001529_abnormal_vocalization | 2.42029003 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.41003062 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.35597866 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.33189036 |
| 22 | MP0001970_abnormal_pain_threshold | 2.27701119 |
| 23 | MP0001486_abnormal_startle_reflex | 2.26083669 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.10580866 |
| 25 | MP0001905_abnormal_dopamine_level | 2.06247796 |
| 26 | MP0003122_maternal_imprinting | 1.98594455 |
| 27 | MP0002184_abnormal_innervation | 1.97495214 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.93857702 |
| 29 | MP0004924_abnormal_behavior | 1.93857702 |
| 30 | MP0004858_abnormal_nervous_system | 1.79636012 |
| 31 | MP0001984_abnormal_olfaction | 1.74554679 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.74206399 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.72333620 |
| 34 | MP0000778_abnormal_nervous_system | 1.72270620 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.62766756 |
| 36 | MP0003329_amyloid_beta_deposits | 1.57574135 |
| 37 | MP0004142_abnormal_muscle_tone | 1.55946130 |
| 38 | MP0003787_abnormal_imprinting | 1.54561688 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.53458087 |
| 40 | MP0008569_lethality_at_weaning | 1.49848342 |
| 41 | MP0001188_hyperpigmentation | 1.46272475 |
| 42 | MP0000955_abnormal_spinal_cord | 1.46138281 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.45472689 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.43525263 |
| 45 | MP0003879_abnormal_hair_cell | 1.39486502 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.36945745 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.36176737 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.33713766 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.24933577 |
| 50 | MP0008872_abnormal_physiological_respon | 1.24188297 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.20605734 |
| 52 | MP0000751_myopathy | 1.16017937 |
| 53 | MP0000920_abnormal_myelination | 1.15680722 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.14279880 |
| 55 | MP0003690_abnormal_glial_cell | 1.11096584 |
| 56 | MP0003633_abnormal_nervous_system | 1.06836528 |
| 57 | MP0002152_abnormal_brain_morphology | 0.99955615 |
| 58 | MP0003631_nervous_system_phenotype | 0.97343730 |
| 59 | MP0002638_abnormal_pupillary_reflex | 0.94550165 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 0.94341438 |
| 61 | MP0005535_abnormal_body_temperature | 0.94328666 |
| 62 | MP0002229_neurodegeneration | 0.94053410 |
| 63 | MP0005394_taste/olfaction_phenotype | 0.93274201 |
| 64 | MP0005499_abnormal_olfactory_system | 0.93274201 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.90108259 |
| 66 | MP0004147_increased_porphyrin_level | 0.89596716 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.86494092 |
| 68 | MP0008874_decreased_physiological_sensi | 0.84683081 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.84334573 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.83989877 |
| 71 | MP0001664_abnormal_digestion | 0.83688562 |
| 72 | MP0002751_abnormal_autonomic_nervous | 0.82898499 |
| 73 | MP0004742_abnormal_vestibular_system | 0.82666665 |
| 74 | MP0002752_abnormal_somatic_nervous | 0.81444822 |
| 75 | MP0001963_abnormal_hearing_physiology | 0.80916302 |
| 76 | MP0004085_abnormal_heartbeat | 0.79185057 |
| 77 | MP0004885_abnormal_endolymph | 0.77465427 |
| 78 | MP0003861_abnormal_nervous_system | 0.76012909 |
| 79 | MP0003121_genomic_imprinting | 0.71000625 |
| 80 | MP0003634_abnormal_glial_cell | 0.70282928 |
| 81 | MP0003632_abnormal_nervous_system | 0.68691533 |
| 82 | MP0005623_abnormal_meninges_morphology | 0.67697778 |
| 83 | MP0001177_atelectasis | 0.66108944 |
| 84 | MP0002090_abnormal_vision | 0.66108723 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.65198229 |
| 86 | MP0000604_amyloidosis | 0.65093512 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.63313303 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.61900235 |
| 89 | MP0001943_abnormal_respiration | 0.60535122 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.60264138 |
| 91 | MP0004484_altered_response_of | 0.60045624 |
| 92 | MP0010768_mortality/aging | 0.59687300 |
| 93 | MP0003123_paternal_imprinting | 0.59663181 |
| 94 | MP0005409_darkened_coat_color | 0.59055333 |
| 95 | MP0000579_abnormal_nail_morphology | 0.58294528 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.58023139 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.57731017 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.55553399 |
| 99 | MP0003646_muscle_fatigue | 0.54367702 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.54061605 |
| 101 | MP0006072_abnormal_retinal_apoptosis | 0.53952640 |
| 102 | MP0008877_abnormal_DNA_methylation | 0.52104602 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.52038215 |
| 104 | MP0004233_abnormal_muscle_weight | 0.51977799 |
| 105 | MP0002873_normal_phenotype | 0.51496938 |
| 106 | MP0003938_abnormal_ear_development | 0.50783300 |
| 107 | MP0002169_no_abnormal_phenotype | 0.50390783 |
| 108 | MP0003183_abnormal_peptide_metabolism | 0.50139917 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.49777230 |
| 110 | MP0002082_postnatal_lethality | 0.48817082 |
| 111 | MP0010770_preweaning_lethality | 0.48817082 |
| 112 | MP0000026_abnormal_inner_ear | 0.48597927 |
| 113 | MP0000566_synostosis | 0.48269284 |
| 114 | MP0003956_abnormal_body_size | 0.48174127 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.48173654 |
| 116 | MP0010769_abnormal_survival | 0.47510650 |
| 117 | MP0002081_perinatal_lethality | 0.46632046 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.46097948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.41893750 |
| 2 | Myokymia (HP:0002411) | 6.32699163 |
| 3 | Focal seizures (HP:0007359) | 5.43225525 |
| 4 | Atonic seizures (HP:0010819) | 5.15705849 |
| 5 | Visual hallucinations (HP:0002367) | 5.03321532 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.67684096 |
| 7 | Febrile seizures (HP:0002373) | 4.63786878 |
| 8 | Limb dystonia (HP:0002451) | 4.43837090 |
| 9 | Absence seizures (HP:0002121) | 4.27293788 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.15916677 |
| 11 | Dialeptic seizures (HP:0011146) | 3.91355275 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.81332939 |
| 13 | Pheochromocytoma (HP:0002666) | 3.56564670 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.50908851 |
| 15 | Hyperventilation (HP:0002883) | 3.32600130 |
| 16 | Neuroendocrine neoplasm (HP:0100634) | 3.26382745 |
| 17 | Polyphagia (HP:0002591) | 3.22399788 |
| 18 | Failure to thrive in infancy (HP:0001531) | 3.17915899 |
| 19 | Abnormal eating behavior (HP:0100738) | 3.16320426 |
| 20 | Broad-based gait (HP:0002136) | 3.10565499 |
| 21 | Amblyopia (HP:0000646) | 3.06308820 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.04347741 |
| 23 | Action tremor (HP:0002345) | 3.02547704 |
| 24 | Ankle clonus (HP:0011448) | 3.00911018 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00885240 |
| 26 | Progressive inability to walk (HP:0002505) | 2.99791965 |
| 27 | Abnormal hair whorl (HP:0010721) | 2.97627428 |
| 28 | Anxiety (HP:0000739) | 2.91890091 |
| 29 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.85846199 |
| 30 | Intention tremor (HP:0002080) | 2.85307149 |
| 31 | Depression (HP:0000716) | 2.82888077 |
| 32 | Peripheral hypomyelination (HP:0007182) | 2.80465923 |
| 33 | Truncal ataxia (HP:0002078) | 2.79842315 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 2.77585881 |
| 35 | Hypothermia (HP:0002045) | 2.76531088 |
| 36 | Annular pancreas (HP:0001734) | 2.75632052 |
| 37 | Neuronal loss in central nervous system (HP:0002529) | 2.74024213 |
| 38 | Gait imbalance (HP:0002141) | 2.68974220 |
| 39 | Poor eye contact (HP:0000817) | 2.66724347 |
| 40 | Mutism (HP:0002300) | 2.66427328 |
| 41 | Tetraplegia (HP:0002445) | 2.62984970 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.62520831 |
| 43 | Termporal pattern (HP:0011008) | 2.62448139 |
| 44 | Insidious onset (HP:0003587) | 2.62448139 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.61402977 |
| 46 | Rigidity (HP:0002063) | 2.57964927 |
| 47 | Poor suck (HP:0002033) | 2.57063720 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 2.54831070 |
| 49 | Hypoventilation (HP:0002791) | 2.54458712 |
| 50 | Epileptiform EEG discharges (HP:0011182) | 2.53344963 |
| 51 | Dysmetria (HP:0001310) | 2.49375165 |
| 52 | Abnormality of the corticospinal tract (HP:0002492) | 2.47767162 |
| 53 | Impaired social interactions (HP:0000735) | 2.45923136 |
| 54 | Abnormal social behavior (HP:0012433) | 2.45923136 |
| 55 | Hemiplegia (HP:0002301) | 2.42667620 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.42334894 |
| 57 | Urinary urgency (HP:0000012) | 2.41426283 |
| 58 | Drooling (HP:0002307) | 2.40944742 |
| 59 | Excessive salivation (HP:0003781) | 2.40944742 |
| 60 | CNS hypomyelination (HP:0003429) | 2.40844809 |
| 61 | Fetal akinesia sequence (HP:0001989) | 2.39474334 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.38718247 |
| 63 | Apathy (HP:0000741) | 2.38538222 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.38048888 |
| 65 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.38048888 |
| 66 | Bradykinesia (HP:0002067) | 2.38004997 |
| 67 | Inability to walk (HP:0002540) | 2.36982904 |
| 68 | Diplopia (HP:0000651) | 2.36390434 |
| 69 | Abnormality of binocular vision (HP:0011514) | 2.36390434 |
| 70 | Progressive macrocephaly (HP:0004481) | 2.35421733 |
| 71 | Insomnia (HP:0100785) | 2.35250618 |
| 72 | Spastic gait (HP:0002064) | 2.34712051 |
| 73 | Diminished movement (HP:0002374) | 2.28989811 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.28804033 |
| 75 | Torticollis (HP:0000473) | 2.27237668 |
| 76 | Congenital primary aphakia (HP:0007707) | 2.25595838 |
| 77 | Delusions (HP:0000746) | 2.24724162 |
| 78 | Diminished motivation (HP:0000745) | 2.23810722 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.23614552 |
| 80 | Focal dystonia (HP:0004373) | 2.21609215 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 2.18616443 |
| 82 | Akinesia (HP:0002304) | 2.17654087 |
| 83 | Specific learning disability (HP:0001328) | 2.17638127 |
| 84 | Abnormality of the lower motor neuron (HP:0002366) | 2.17289905 |
| 85 | Impaired pain sensation (HP:0007328) | 2.17066612 |
| 86 | Abnormality of pain sensation (HP:0010832) | 2.17066612 |
| 87 | Obstructive sleep apnea (HP:0002870) | 2.16461813 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.13015702 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12386663 |
| 90 | Clonus (HP:0002169) | 2.11881840 |
| 91 | Spastic tetraparesis (HP:0001285) | 2.11537898 |
| 92 | Scanning speech (HP:0002168) | 2.11348930 |
| 93 | Postural instability (HP:0002172) | 2.10946162 |
| 94 | Rapidly progressive (HP:0003678) | 2.10505258 |
| 95 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.10034995 |
| 96 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.09234546 |
| 97 | Esotropia (HP:0000565) | 2.09136375 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.08144885 |
| 99 | Genital tract atresia (HP:0001827) | 2.08094873 |
| 100 | Craniofacial dystonia (HP:0012179) | 2.06682154 |
| 101 | Hemiparesis (HP:0001269) | 2.06018745 |
| 102 | Agitation (HP:0000713) | 2.05206417 |
| 103 | Hyperthyroidism (HP:0000836) | 2.04477429 |
| 104 | Choreoathetosis (HP:0001266) | 2.04272874 |
| 105 | Oligomenorrhea (HP:0000876) | 2.04157999 |
| 106 | Mitochondrial inheritance (HP:0001427) | 2.01953006 |
| 107 | Abnormality of the labia minora (HP:0012880) | 2.01905470 |
| 108 | Lower limb muscle weakness (HP:0007340) | 2.01092866 |
| 109 | Vaginal atresia (HP:0000148) | 2.00959690 |
| 110 | Neurofibrillary tangles (HP:0002185) | 1.99352795 |
| 111 | Spastic tetraplegia (HP:0002510) | 1.99228021 |
| 112 | Genetic anticipation (HP:0003743) | 1.98368533 |
| 113 | Psychosis (HP:0000709) | 1.98022677 |
| 114 | Stereotypic behavior (HP:0000733) | 1.97851111 |
| 115 | Absent speech (HP:0001344) | 1.95736243 |
| 116 | Muscular hypotonia of the trunk (HP:0008936) | 1.94897038 |
| 117 | Hypokinesia (HP:0002375) | 1.94325444 |
| 118 | Abnormality of saccadic eye movements (HP:0000570) | 1.94251516 |
| 119 | Impaired smooth pursuit (HP:0007772) | 1.93954567 |
| 120 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.92527374 |
| 121 | Generalized myoclonic seizures (HP:0002123) | 1.91801244 |
| 122 | Impaired vibratory sensation (HP:0002495) | 1.91107597 |
| 123 | Resting tremor (HP:0002322) | 1.88874082 |
| 124 | Sleep apnea (HP:0010535) | 1.88169896 |
| 125 | Papilledema (HP:0001085) | 1.88064023 |
| 126 | Incomplete penetrance (HP:0003829) | 1.87873305 |
| 127 | Hypoplasia of the brainstem (HP:0002365) | 1.87703693 |
| 128 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.87703693 |
| 129 | Narrow nasal bridge (HP:0000446) | 1.86768092 |
| 130 | Status epilepticus (HP:0002133) | 1.86612711 |
| 131 | Dyskinesia (HP:0100660) | 1.85074963 |
| 132 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78298831 |
| 133 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.74976722 |
| 134 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74976722 |
| 135 | Aplasia involving bones of the extremities (HP:0009825) | 1.74976722 |
| 136 | Gait ataxia (HP:0002066) | 1.72786880 |
| 137 | Neonatal onset (HP:0003623) | 1.72664453 |
| 138 | Megalencephaly (HP:0001355) | 1.72520589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.07275320 |
| 2 | CASK | 3.62995403 |
| 3 | MAP3K12 | 3.56577715 |
| 4 | MAP3K9 | 3.47961163 |
| 5 | MAP3K4 | 3.43634600 |
| 6 | MAP2K7 | 3.14930870 |
| 7 | MARK1 | 3.14408719 |
| 8 | EPHA4 | 3.02976193 |
| 9 | MINK1 | 2.68072025 |
| 10 | MAP2K4 | 2.22133210 |
| 11 | GRK5 | 2.09433235 |
| 12 | DAPK2 | 2.04785383 |
| 13 | NTRK1 | 1.97925930 |
| 14 | NTRK2 | 1.94997663 |
| 15 | PLK2 | 1.94234564 |
| 16 | ARAF | 1.91348183 |
| 17 | PNCK | 1.78584752 |
| 18 | KSR2 | 1.73140000 |
| 19 | DAPK1 | 1.62903823 |
| 20 | RIPK4 | 1.62818278 |
| 21 | PAK6 | 1.59790464 |
| 22 | MAPK13 | 1.58138196 |
| 23 | CDK19 | 1.52106472 |
| 24 | CDK5 | 1.41036801 |
| 25 | KSR1 | 1.30479512 |
| 26 | PRKCG | 1.29870938 |
| 27 | MAP3K11 | 1.19688363 |
| 28 | NME1 | 1.15824535 |
| 29 | CAMK2A | 1.14714880 |
| 30 | TNIK | 1.10840764 |
| 31 | CSNK1G2 | 1.09321731 |
| 32 | GRK7 | 1.08425118 |
| 33 | PHKG1 | 1.06831352 |
| 34 | PHKG2 | 1.06831352 |
| 35 | PRPF4B | 1.05717873 |
| 36 | LATS2 | 1.02726543 |
| 37 | UHMK1 | 1.02327995 |
| 38 | SIK2 | 1.00331904 |
| 39 | CAMKK1 | 1.00122486 |
| 40 | AKT3 | 1.00102545 |
| 41 | SGK223 | 0.97560685 |
| 42 | SGK494 | 0.97560685 |
| 43 | CDK18 | 0.96946488 |
| 44 | ALK | 0.96929019 |
| 45 | FES | 0.96169937 |
| 46 | CDK14 | 0.95614363 |
| 47 | OXSR1 | 0.94638327 |
| 48 | CAMK2B | 0.93149578 |
| 49 | CDK15 | 0.92325973 |
| 50 | TSSK6 | 0.86263188 |
| 51 | SGK2 | 0.84674787 |
| 52 | BRSK1 | 0.82532488 |
| 53 | MAP3K13 | 0.80653895 |
| 54 | PTK2B | 0.80193872 |
| 55 | CDK11A | 0.79660481 |
| 56 | CAMKK2 | 0.79217630 |
| 57 | MAP3K2 | 0.78773002 |
| 58 | CSNK1G3 | 0.77507306 |
| 59 | PKN1 | 0.75232826 |
| 60 | RET | 0.74707866 |
| 61 | SIK3 | 0.74249729 |
| 62 | BRAF | 0.74161178 |
| 63 | MAPK12 | 0.73734824 |
| 64 | ADRBK2 | 0.73375357 |
| 65 | PRKD3 | 0.73131832 |
| 66 | MAPKAPK5 | 0.72384394 |
| 67 | PRKCE | 0.70325270 |
| 68 | STK38 | 0.66956388 |
| 69 | DYRK1A | 0.66736558 |
| 70 | ADRBK1 | 0.65305222 |
| 71 | PAK3 | 0.64100085 |
| 72 | CCNB1 | 0.64024785 |
| 73 | BMPR2 | 0.63087725 |
| 74 | NEK6 | 0.59618497 |
| 75 | CAMK2G | 0.59124164 |
| 76 | CAMK2D | 0.58913506 |
| 77 | RAF1 | 0.58095075 |
| 78 | CAMK1 | 0.57881901 |
| 79 | LMTK2 | 0.57181571 |
| 80 | LIMK1 | 0.57109525 |
| 81 | STK11 | 0.56872510 |
| 82 | RIPK1 | 0.56669194 |
| 83 | FER | 0.56607455 |
| 84 | MAP2K1 | 0.56572182 |
| 85 | MAPK10 | 0.56322283 |
| 86 | PDK3 | 0.55043284 |
| 87 | PDK4 | 0.55043284 |
| 88 | FGR | 0.54384312 |
| 89 | CAMK4 | 0.53802056 |
| 90 | RPS6KA3 | 0.53401388 |
| 91 | CAMK1G | 0.52704988 |
| 92 | PRKCH | 0.52214778 |
| 93 | TNK2 | 0.51960088 |
| 94 | BCR | 0.50595268 |
| 95 | SGK1 | 0.50574196 |
| 96 | WNK3 | 0.49355244 |
| 97 | SGK3 | 0.48193306 |
| 98 | MAP3K1 | 0.47879227 |
| 99 | TYRO3 | 0.47827589 |
| 100 | RPS6KA2 | 0.47761237 |
| 101 | NEK1 | 0.46052208 |
| 102 | TESK1 | 0.44338889 |
| 103 | PDK1 | 0.44165053 |
| 104 | PRKCZ | 0.42842052 |
| 105 | MARK2 | 0.40581085 |
| 106 | ROCK2 | 0.40109840 |
| 107 | DAPK3 | 0.39890374 |
| 108 | PINK1 | 0.39794636 |
| 109 | MAP3K6 | 0.39218503 |
| 110 | CSNK1E | 0.38877422 |
| 111 | CSNK1G1 | 0.38418798 |
| 112 | PRKG2 | 0.36932882 |
| 113 | GRK6 | 0.36373289 |
| 114 | DYRK2 | 0.36367725 |
| 115 | PRKACA | 0.36203749 |
| 116 | PRKCA | 0.33765509 |
| 117 | DMPK | 0.33361352 |
| 118 | MAPK8 | 0.32726015 |
| 119 | FYN | 0.31523748 |
| 120 | CAMK1D | 0.31302079 |
| 121 | CSNK1D | 0.29136566 |
| 122 | PDPK1 | 0.27335929 |
| 123 | PRKG1 | 0.26776745 |
| 124 | GSK3B | 0.26087314 |
| 125 | CSNK1A1 | 0.24422837 |
| 126 | CSNK1A1L | 0.23618348 |
| 127 | PRKCB | 0.23123334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.10669398 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.03245060 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.88240142 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72853423 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67822752 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.57974694 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.49170629 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45564302 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.43278289 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36795840 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29769984 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.27148911 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.10502279 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10334395 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.98250401 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.93631453 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92684673 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.92102704 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.85328138 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83403517 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82298629 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.78539047 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71367007 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.67447013 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.63406034 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60123832 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54863113 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.49980466 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48485319 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.47259531 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42082793 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41134840 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37570356 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36510248 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.29789389 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28743676 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.26706960 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25389454 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.08496861 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06935997 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.00955052 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00884044 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99332650 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98481153 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 0.97502311 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96989427 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96457541 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90570398 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 0.86073179 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82991773 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81907974 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.78813808 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78683331 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77777392 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77339079 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77038772 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76567126 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65633500 |
| 59 | Alcoholism_Homo sapiens_hsa05034 | 0.63283061 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61958803 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60218255 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.58693570 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57953777 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56891244 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56452741 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55334135 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53934704 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53435785 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53051774 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50018353 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49915947 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49072798 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47704753 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47096933 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46505822 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43619767 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42933702 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42900632 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42297766 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42132055 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39978915 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39082679 |
| 83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38702282 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37223718 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35083103 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.34356244 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33815032 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32949091 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32674553 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31424357 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31324270 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30957204 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30945667 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30234694 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30171092 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.29233823 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28348524 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26910571 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26735032 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25676400 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24467661 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23725293 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23496685 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23082492 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22924999 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22920330 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.22845815 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22845710 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21911597 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.21713288 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.19721052 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19606893 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17304300 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16918776 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.15256700 |

